106848-38-8

Basic information

• Product Name: 1-BENZYL-4-BROMOIMIDAZOLE
• Synonyms: 1-BENZYL-4-BROMOIMIDAZOLE;1-benzyl-4-broMo-1H-iMidazole
• CAS NO: 106848-38-8
• Molecular Formula: C₁₀H₉BrN₂
• Molecular Weight: 237.09586
• Mol File: 106848-38-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-BENZYL-4-BROMOIMIDAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BENZYL-4-BROMOIMIDAZOLE(106848-38-8)
• EPA Substance Registry System: 1-BENZYL-4-BROMOIMIDAZOLE(106848-38-8)

Safety Data

• Hazardous Substances Data: 106848-38-8(Hazardous Substances Data)

Usage

General Description

1-Benzyl-4-bromoimidazole is a chemical compound with the molecular formula C10H9BrN2. It is a brominated imidazole derivative that is commonly used as a building block in synthetic chemistry. Imidazoles are known for their wide range of biological activities, and 1-benzyl-4-bromoimidazole has been investigated for its potential pharmacological applications, particularly in the field of medicinal chemistry. 1-BENZYL-4-BROMOIMIDAZOLE may be used as a starting material for the synthesis of various pharmaceuticals and active ingredients in drug development. Its unique structure and properties make it a valuable and versatile compound in chemical and biological research.

Upstream product

• 101853-78-5 1-benzyl-4,5-dibromo-1H-imidazole 
• 2302-25-2 4-bromo-1 H-imidazole 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 
• 31250-80-3 1-benzyl-2,4,5-tribromo-1H-imidazole 

Downstream Products

• 4238-71-5 1-benzylimidazole 
• 1000980-03-9 1-benzyl-1H-imidazole-4-carbonitrile 
• 1449431-63-3 methyl 4-(3-(1-benzyl-1H-imidazol-4-yl)-1-hydroxy-1H-pyrazol-4-yl)piperidine-1-carboxylate 
• 1449431-58-6 3-(1-benzyl-1H-imidazol-4-yl)-4-(piperidin-4-yl)-1H-pyrazol-1-ol 
• 1449431-51-9 methyl 4-(5-(1-benzyl-2-chloro-1H-imidazol-4-yl)-1-(benzyloxy)-1H-pyrazol-4-yl)piperidine-1-carboxylate 
• 1449431-48-4 methyl 4-(3-(1-benzyl-2-chloro-1H-imidazol-4-yl)-1-(benzyloxy)-1H-pyrazol-4-yl)piperidine-1-carboxylate 
• 1449431-55-3 4-(3-(1-benzyl-2-chloro-1H-imidazol-4-yl)-1-hydroxy-1H-pyrazol-4-yl)piperidinium hydrogen bromide 
• 1380248-41-8 N-(1-benzyl-1H-imidazol-4-yl)benzamide 

Relevant articles and documents

NaBH4-TMEDA and a palladium catalyst as efficient regio- and chemoselective system for the hydrodehalogenation of halogenated heterocycles

The pair NaBH4-TMEDA as hydride source and a palladium catalyst in THF prove to be an efficient system for the hydrodehalogenation of halogenated heterocycles with one or more heteroatoms. In general, Pd(OAc) 2-PPh3 rapidly hydrodehalogenates reactive halo-heterocycles such as bromo-pyridines, -quinolines, -thiophenes, -indoles, -imidazoles, etc., at room temperature in very good yields, whereas in most cases PdCl2(dppf) reduces less reactive halides such as chloro-pyridines, -quinolines, -pyrimidines and bromo-indoles, -benzofurans, etc. Moreover, PdCl2(tbpf) shows to be even more active removing the 2- and 5-chlorine from both thiophene and thiazole rings. The reaction conditions tolerate various functional groups, allowing highly chemoselective reactions in the presence of halide, ester, alkyne, alkene and nitrile substituents. Moreover, with a proper selection of the catalyst it is also possible to obtain a good control in the regioselective hydrodehalogenation of a variety of polyhalogenated substrates.

A general, practical palladium-catalyzed cyanation of (hetero)aryl chlorides and bromides

Playing it safe: The nontoxic cyanide source K4[Fe(CN) 6]×3 H2O can be used for the cyanation of (hetero)aryl halides. The application of palladacycle catalysts prevents poisoning during catalyst formation, thereby allowing for low catalyst loadings, fast reaction times, and wide heterocyclic substrate scope.

Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists

Structure-activity relationship (SAR) studies were conducted around early tetrazole-based leads 3 and 4. Replacements for the tetrazole core were investigated and the pendant benzyl substitution was reoptimized with a triazole isostere. Triazole-based P2X